bg
I

Inhibrx (INBX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Inhibrx (INBX)

Inhibrx Inc. is a clinical-stage biotechnology company. The Company is focused on developing biologic therapeutics for people with life-threatening conditions. It has a pipeline of novel biologic therapeutic candidates, developed using its single dom... Read more

  • USD34.31
  • USD34.45
  • USD34.07
  • USD39.79
  • -2.20%
  • 2M
  • 218.29k
  • 419.38k
  • 1.6B
  • 14.31
  • 60.80%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App